Table 1.
Summary of study characteristics
Study name, year | |||
---|---|---|---|
| |||
COMBAT, 2018 | PAMPer, 2018 | PREHO-PLYO, 2022 | |
Study design | RCT | RCT | RCT |
Population (P) | 65 | 230 | 68 |
Population (C) | 60 | 271 | 66 |
Median age (P) | 33.0 (25.0–51.0) | 44.0 (21.0–59.0) | 36.6 (26.8–49.5) |
Median age (C) | 32.5 (25.5–42.0) | 46.0 (29–60.0) | 33.6 (25.2–47.6) |
ISS (P) | 27.0 (10.0–41.0) | 22.0 (14.0–33.0) | 29 (12.0–48.0) |
ISS (C) | 27.0 (11.5–36.0) | 21.0 (12.0–29.0) | 25.0 (9.0–41.0) |
All data are presented in number or median and IQR. P: Plasma group, C: Control group, IQR: Interquartile range, RCT: Randomized controlled trial, ISS: Injury severity score